Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates

Infection and Immunity

Volumn 71, Issue 6, 2003, Pages 3034-3042

  Philippe, B ^a,e   Ibrahim Granet, O ^a   Prevost M C ^a   Gougerot Pocidalo, M A ^b   Perez, M Sanchez ^d   Van der Meeren, A ^c   Latge J P ^a  

^a INSTITUT PASTEUR   (France)

^b BICHAT HOSPITAL   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d UNIVERSITY OF SALAMANCA   (Spain)

^e FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTISONE ACETATE; NITRIC OXIDE SYNTHASE; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; CONGENIC STRAIN; CONIDIUM; CONTROLLED STUDY; ENZYME INHIBITION; FUNGICIDAL ACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; STEROID ANALYSIS; WILD TYPE;

ADRENAL CORTEX HORMONES; ANIMALS; ASPERGILLUS FUMIGATUS; MACROPHAGES, ALVEOLAR; MICE; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES;

EID: 0037900003     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.6.3034-3042.2003     Document Type: Article

References (37)

1. Bellamy, R. 1999. The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens. Microbes Infect. 1:23-27.
2. Brummer, E., A. Maqbool, and D. A. Stevens. 2001. Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia. Med. Mycol. 39:509-515.
3. Cacciapuoti, A., D. Loebenberg, E. Corcoran, F. Menzel, Jr., E. L. Moss, Jr., C. Norris, M. Michalski, K. Raynor, J. Halpern, C. Mendrick, B. Arnold, B. Antonacci, R. Parmegiani, T. Yarosh-Tomaine, G. H. Miller, and R. S. Hare. 2000. In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrob. Agents Chemother. 44:2017-2022.
4. Cenci, E., A. Mencacci, A. Bacci, F. Bistoni, V. P. Kurup, and L. Romani. 2000. T cell vaccination in mice with invasive pulmonary aspergillosis. J. Immunol. 165:381-388.
5. 2 diffusion. FEMS Immunol. Med. Microbiol. 13:19-28.
6. - in alveolar macrophages. J. Neuroimmunol. 108:68-72.
7. Groll, A. H., P. M. Shah, C. Mentzel, M. Schneider, G. Just-Nuebling, and K. Huebner. 1996. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33:23-32.
8. Hashimoto, S., K. Nomoto, and T. Yokokura. 1986. The role of superoxide anion and lysosomal enzymes in anti-listerial activity of elicited peritoneal macrophages. Scand. J. Immunol. 24:429-436.
9. Ibrahim-Granet, O., B. Philippe, H. Boleti, E. Boisvieux-Ulrich, D. Grenet, M. Stern, and J. P. Latgé. 2003 Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect. Immun. 71:891-903.
10. Jahn, B., A. Rampp, C. Dick, A. Jahn, M. Palmer, and S. Bhakdi. 1998. Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell level. Antimicrob. Agents Chemother. 42:2569-2575.
11. Jaton-Ogay, K., S. Paris, M. Huerre, M. Quadroni, R. Falchetto, G. Togni, J. P. Latgé, and M. Monod. 1994. Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol. Microbiol. 14:917-928.
12. Johansson, A., and C. Dahlgren. 1992. Differentiation of human peripheral blood monocytes to macrophages is associated with changes in the cellular respiratory burst activity. Cell Biochem. Funct. 10:87-93.
13. Latgé, J. P. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12:310-350.
14. Lehnert, B. E., Y. E. Valdez, R. J. Sebring, N. M. Lehnert, G. C. Saunders, and J. A. Steinkamp. 1990. Airway intra-luminal macrophages: evidence of origin and comparisons to alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 3:377-391.
15. Levitz, S., and R. Diamond. 1985. Mechanism of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro. J. Infect. Dis. 152:33-42.
16. Levitz, S. M., M. E. Selsted, T. Ganz, R. I. Lehrer, and R. D. Diamond. 1986. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J. Infect. Dis. 154:483-489.
17. Madan, T., P. Eggleton, U. Kishore, P. Strong, S. S. Aggrawal, P. U. Sarma, and K. B. Reid. 1997. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect. Immun. 65:3171-3179.
18. - generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J. Clin. Investig. 83:1936-1940.
19. Marr, K. A., R. A. Carter, F. Crippa, A. Wald, and L. Corey. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:909-917.
20. Marr, K. A., M. Koudadoust, M. Black, and S. A. Balajee. 2001. Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay. Clin. Diagn. Lab. Immunol. 8:1240-1247.
21. Meier-Osusky, I., G. Schoedon, F. Blauer, M. Schneemann, and A. Schaffner. 1996. Comparison of the antimicrobial activity of deactivated human macrophages challenged with Aspergillus fumigatus and Listeria monocytogenes. J. Infect. Dis. 174:651-654.
22. Michaliszyn, E., S. Senechal, P. Martel, and L. de Repentigny. 1995. Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages. Infect. Immun. 63:2075-2078.
23. Mitsuyama, M., R. Ohara, K. Amako, K. Nomoto, and T. Yokokura. 1986. Ontogeny of macrophage function to release superoxide anion in conventional and germfree mice. Infect. Immun. 52:236-239.
24. Morgenstern, D. E., M. A. Gifford, L. L. Li, C. M. Doerschuk, and M. C. Dinauer. 1997. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J. Exp. Med. 185:207-218.
25. Murayama, T., R. Amitani, Y. Ikegami, R. Nawada, W. J. Lee, and F. Kuze. 1996. Suppressive effects of Aspergillus fumigatus culture filtrates on human alveolar macrophages and polymorphonuclear leucocytes. Eur. Respir. J. 9:293-300.
26. Nessa, K., L. Palmberg, U. Johard, P. Malmberg, C. Jarstrand, and P. Camner. 1997. Reaction of human alveolar macrophages to exposure to Aspergillus fumigatus and inert particles. Environ. Res. 75:141-148.
27. Phillips, D. M., R. Pearce-Pratt, X. Tan, and V. R. Zacharopoulos. 1992. Association of mycoplasma with HIV-1 and HTLV-1 in human T lymphocytes. AIDS Res. Hum. Retrovir. 8:1863-1868.
28. + flux. Nature 416:291-297.
29. Robertson, M. D., K. M. Kerr, and A. Seaton. 1989. Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heatlabile serum components. J. Med. Vet. Mycol. 27:295-302.
30. Roilides, E., A. Dimitriadou-Georgiadou, T. Sein, I. Kadiltsoglou, and T. J. Walsh. 1998. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect. Immun. 66:5999-6003.
31. Schaffner, A. 1985. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J. Clin. Investig. 76:1755-1764.
32. Schaffner, A., H. Douglas, A. I. Braude, and C. E. Davis. 1983. Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect. Immun. 42:1109-1115.
33. Shahan, T. A., W. G. Sorenson, and D. M. Lewis. 1994. Superoxide anion production in response to bacterial lipopolysaccharide and fungal spores implicated in organic dust toxic syndrome. Environ. Res. 67:98-107.
34. Sturtevant, J., and J. P. Latgé. 1992. Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells. J. Infect. Dis. 166:580-586.
35. Wald, A., W. Leisenring, J. A. van Burik, and R. A. Bowden. 1997. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175:1459-1466.
36. Waldorf, A. R., S. M. Levitz, and R. D. Diamond. 1984. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect. Dis. 150:752-760.
37. Winkelstein, J. A., M. C. Marino, R. B. Johnston, Jr., J. Boyle, J. Curnutte, J. I. Gallin, H. L. Malech, S. M. Holland, H. Ochs, P. Quie, R. H. Buckley, C. B. Foster, S. J. Chanock, and H. Dickler. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169.